Cite Filings / SMMT / 0001599298-22-000100
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Summit Therapeutics Inc. · Filed 2022-08-16 · Acc 0001599298-22-000100

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , smmt-20220815.htm

Around this filing

  • 2022-10-03 8-K Executive or director change
  • 2022-08-18 SC 13D/A Beneficial Ownership Report
  • 2022-08-18 4 Chief Executive Officer bought 94,849,203 shares at $0.97 ($92,003,727)
  • 2022-08-18 4 Co-CEO & President bought 5,809,132 shares at $0.97 ($5,634,858)
  • 2022-08-17 4 Chief Financial Officer bought 36,215 shares at $0.97 ($35,129)
  • 2022-08-16 8-K Other events
  • 2022-08-11 8-K Results of operations

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading smmt-20220815.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…